Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization

NCT03405402 is registered in ClinicalTrials.gov with Hanane EL KENZ as lead sponsor.

NCT NCT03405402
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03405402 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization
Lead sponsor
Hanane EL KENZ
Phase
Not applicable
Overall status
Completed
Start date
February 13, 2018
Completion date
August 3, 2020
Enrollment
173 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sickle cell disease